Filed: 11/7/2025ACC: 0001104659-25-108546
📋 What this filing means
REGENERON PHARMACEUTICALS, INC. filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $700.44M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$700.44M
Total AUM (reported)
6.24M
Total Shares
Allocation by class
COMMON STOCK$700.44M100.0%
Portfolio Concentration
Top 3$699.66M99.9%
4–10$784.4K0.1%
Top 3 weight
99.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 6.24M
Sole
Full voting authority
6.24M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole4
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
Alnylam Pharmaceuticals, Inc.
SOLEShares1.39M
TypeSH
Market value$634.89M
90.64%
Sole
1.39M
Shared
0.00
None
0.00
Intellia Therapeutics, Inc.
SOLEShares3.70M
TypeSH
Market value$63.95M
9.13%
Sole
3.70M
Shared
0.00
None
0.00
Adverum Biotechnologies, Inc.
SOLEShares180.91K
TypeSH
Market value$819.5K
0.12%
Sole
180.91K
Shared
0.00
None
0.00
Adicet Bio, Inc.
SOLEShares968.18K
TypeSH
Market value$784.4K
0.11%
Sole
968.18K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc.SOLE | Common Stock | 1.39M | SH | $634.89M 90.64% | 1.39M | 0.00 | 0.00 |
Intellia Therapeutics, Inc.SOLE | Common Stock | 3.70M | SH | $63.95M 9.13% | 3.70M | 0.00 | 0.00 |
Adverum Biotechnologies, Inc.SOLE | Common Stock | 180.91K | SH | $819.5K 0.12% | 180.91K | 0.00 | 0.00 |
Adicet Bio, Inc.SOLE | Common Stock | 968.18K | SH | $784.4K 0.11% | 968.18K | 0.00 | 0.00 |